Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman
4 विचारों
• 07/30/23
0
0
एम्बेड
administrator
ग्राहकों
A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd
और दिखाओ
फेसबुक टिप्पणियाँ
SORT BY-
सबसे ऊपर की टिप्पणी
-
नवीनतम टिप्पणियां